Chemical Structure : MLN3126
CAS No.: 628300-71-0
Catalog No.: PC-35220Not For Human Use, Lab Use Only.
MLN3126 (MLN 3126, MLN-3126) is a potent, selective, orally available CCR9 antagonist with IC50 of 6.3 nM (CCL25-induced calcium mobilization).
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $188 | In stock | |
| 10 mg | $298 | In stock | |
| 25 mg | $498 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MLN3126 (MLN 3126, MLN-3126) is a potent, selective, orally available CCR9 antagonist with IC50 of 6.3 nM (CCL25-induced calcium mobilization).
MLN3126 shows no significant antagonistic activity for other 12 chemokine receptors (CCR1, -2b, -4, -6, -7, -8, -10,CX3CR1, CXCR1, -2, -3 and -4) at 10 uM.
MLN3126 dose dependently inhibits CCL25-induced chemotaxis of mouse thymocytes (IC90=1.8 uM).
MLN3126 ameliorates inflammation in a T cell mediated mouse colitis model.
| M.Wt | 446.902 | |
| Formula | C21H19ClN2O5S | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
N-{4-chloro-2-[(1-oxidopyridin-4-yl)carbonyl]phenyl}-4-(propan-2-yloxy)benzenesulfonamide |
|
1. Igaki K, et al. Int Immunopharmacol. 2018 Jul;60:160-169.
2. Narita N, et al. Drug Metab Dispos. 2018 Mar;46(3):204-213.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright